The Effect of Diethylnitrosamine on the Levels of Sialic Acid, Lipid-Bound Sialic Acid and Enzyme Activities of Transferase in Rat Serum

The aim of this study was to investigate the effects of a chemical carcinogen, Diethylnitrosamine (DENA), on these markers, sialic acid (SA), lipid-bound sialic acid (LBSA) and the liver enzymes aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyltransferase. In this research 180 male Wistar albino rats were used. Rats were divided equally into three groups. Intraperitoneal (i.p.) injection of saline was given to rats in the control group. Treatment group I was given i.p. 100 mg/kg-body weight DENA dissolved in saline. Treatment group II was given i.p. 200 mg/kg-body-weight DENA dissolved in saline. These doses were given to each group just once. Blood samples were taken from fifteen rats, which were chosen randomly from each group per month during the four months. Levels of SA and LBSA and activities of ALT, AST and GGT were determined in serum. Significant elevations in the serum levels of SA and LBSA and activities of ALT, AST and GGT were observed in treatment groups when compared with the controls. In this study, the high levels of enzyme activities, sialic acid, and lipid-bound sialic acid led to hepatocellular degeneration. The results suggest that combined evaluation of these markers (SA and LBSA) and liver enzyme activities can be useful in predicting malignant change.

The Effect of Diethylnitrosamine on the Levels of Sialic Acid, Lipid-Bound Sialic Acid and Enzyme Activities of Transferase in Rat Serum

The aim of this study was to investigate the effects of a chemical carcinogen, Diethylnitrosamine (DENA), on these markers, sialic acid (SA), lipid-bound sialic acid (LBSA) and the liver enzymes aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyltransferase. In this research 180 male Wistar albino rats were used. Rats were divided equally into three groups. Intraperitoneal (i.p.) injection of saline was given to rats in the control group. Treatment group I was given i.p. 100 mg/kg-body weight DENA dissolved in saline. Treatment group II was given i.p. 200 mg/kg-body-weight DENA dissolved in saline. These doses were given to each group just once. Blood samples were taken from fifteen rats, which were chosen randomly from each group per month during the four months. Levels of SA and LBSA and activities of ALT, AST and GGT were determined in serum. Significant elevations in the serum levels of SA and LBSA and activities of ALT, AST and GGT were observed in treatment groups when compared with the controls. In this study, the high levels of enzyme activities, sialic acid, and lipid-bound sialic acid led to hepatocellular degeneration. The results suggest that combined evaluation of these markers (SA and LBSA) and liver enzyme activities can be useful in predicting malignant change.

___

  • Kang, C. B., Kim, C. H., Son, H. S.: Effects of administration of 2,2'-Azobis (2-amidinopropane) dihydrochloride (AAPH) on liver function in rats. 2. Serum enzyme activities. Korean J. Vet. Clin. Med. 1998; 15: 79-82.
  • Moore, M.R., Drinkwater, N.R., Miller, E.C., Miller, J.A., Pitot, H.C.: Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res., 1981; 41: 1585-1593.
  • Bakır, S., Aker, A., Atalay, A.: Dietilnitrosamin’in glukoz-6 fosfat dehidrojenaz, hekzokinaz ve malat dehidrojenaz enzimlerine etkisi. Biyokimya Derg., 1989; 14: 7-12.
  • Chakraborty, A., Selvaraj, S.: Differential modulation of xenobiotic metabolising enzymes by vanadium during diethylnitrosamine induced hepatocarcinogenesis in Sprague- Dawley rats. Neoplasma, 2000; 47: 81-89.
  • Ha, W.S., Kim, C.K., Song, S.H., Kang, C.B.: Study on mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis. J. Vet. Sci. 2001; 2: 53–58.
  • Giuliani, E.R., Zaki, F.G., Hall, J.C.: Serum and hepatic enzyme activity in rats treated with diethylnitrosamine. Toxicol. Pathol., 1983; 11: 23-27.
  • Özkurt, M.: Kanserojen madde verilmifl farelerin karaciğer hücrelerindeki biyokimyasal değifliklikler. Gazi Üniv. Tıp Fak. Biyokimya Anabilim Dalı Uzm. Tezi. 1985.
  • Romppanen, J.: Serum sialic acid in clinical diagnostics. Medical Sciences. 2003; 309: 50 p.
  • Hammond, E. H.: Quality control and standardization for tumor markers. In: Diamandis EP, Fritsche, H.A., Lilja, H., Chan, D.W., Schwartz, M.K.: Tumor markers: Physiology, pathobiology, technology, and clinical applications. Washington, DC: AACC Press. 2002; 25-32.
  • Narayanan, S.: Sialic acid as a tumor marker. Ann. Clin. Lab. Sci., 1994; 24: 376-384.
  • O’Kennedy, R., Berns, G., Moran, E., Smyth, H., Carroll, K., Thornes, R.D., O’Brien, A., Fennely, J., Butler, M.: A critical analysis of the use of sialic acid determination in the diagnosis of malignancy. Cancer Lett., 1991; 58: 91-100.
  • Vedralova, E., Borovansky, J.: Evaluation of serum sialic acid fractions as markers for malignant melanoma. Cancer Lett., 1994; 78: 171-175.
  • Horgan, I.E.: Total and lipid-bound sialic acid levels in sera from patients with cancer. Clin. Chim. Acta., 1982; 118: 327-331.
  • Pönniö, M., Alho, H., Heinälä, P., Nikkari, S.T., Sillanaukee, P.: Serum and saliva levels of sialic acid are elevated in alcoholics. Alcohol Clin. Exp. Res., 1999; 23: 1060-1064.
  • Stefenelli, N., Klotz, H., Engel, A., Bauer, P.: Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. J. Cancer Res. Clin. Oncol., 1985; 109: 55-59.
  • Voigtmann, R., Pokorny, J., Meinshausen, A.: Evaluation and limitations of the lipid-associated sialic acid test for the detection of human cancer. Cancer, 1989; 64: 2279-2283.
  • Warren, L.: The thiobarbituric acid assay of sialic acids. J. Biol. Chem., 1972; 234:1971-1975.
  • Simonsen, R., Uirji, M.A.: Interpreting the profile of liver-function tests in pediatric liver transplants. Clin. Chem., 1984; 30: 1607- 1610.
  • Kim, K.S., Park, J.H.: Antihepatoxic effect of Artemisia Iwayomogi methanol extract on acute hepatic injury by carbon tetrachloride in rat. Korean J. Vet. Res., 1994; 34: 619-626.
  • Huseby, N.E., Ingebretsen, O.C.: The level of gamma- glutamyltransferase in serum, effect of carbohydrate heterogeneity on clearance rate. Scand. J. Clin. Lab. Invest., 1993; 215: 93-100.
  • Schutter, M.J., Visser, J.J., Kamp, G.J., Poully, S.M., Dijk, W., Hilgers, J., Kenemans, P.: The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. Tumour Biol., 1992; 13: 121-132.